Well said. Which is a little concerning because we have so many trials in different areas, yet we have not successfully locked down another major deal. But again its difficult to read into it, Maybe MSB is doing all the pushing back waiting for the right deal, although i find this hard to believe, surely getting money in the door from big pharma is much better than listing on the NASDAQ for $70 odd million coupled with the share price getting hammered. There are no ifs or buts anymore, they need another Big Pharma deal. The only thing that will get the share price moving
Ann: CEO Presentation at JP Morgan Healthcare Conference, page-10
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |